PATENT CLAIM ANALYSIS

Application Number: 16204173
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "130000"]

Abstract:
The present disclosure relates to inhibitors of mitochondrial function. Methods of screening compounds for mitochondrial inhibition are disclosed. Also described are methods of using mitochondrial inhibitors called mitoriboscins—mitochondrial-based therapeutic compounds having anti-cancer and antibiotic properties—to prevent or treat cancer, bacterial infections, and pathogenic yeast, as well as methods of using mitochondrial inhibitors to provide anti-aging benefits. Specific mitoriboscin compounds and groups of mitoriboscins are also disclosed.

Claim (Index 60):
The method of  claim 56 , wherein the mitoriboscin at least one of: possesses anti-aging activity, possesses radiosensitizing activity, possesses photosensitizing activity, sensitizes cancer cells to chemotherapeutic agents, sensitizes cancer cells to natural substances, and sensitizes cancer cells to caloric restriction.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 98.0
- Lexical Diversity: 1.52083
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15551995', '15341961', '13321379', '13071386', '14409793']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7353049309017398
- 35 USC 102 Novelty (BERT): 0.5103651850750819
- Combined Prediction Score: 0.712810956319074
- Mean Citation Score: 200.0031
- Max Citation Score: 203.93298
- Similarity Product: 118.30775737455367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test